Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real‐world effectiveness of first‐line azacitidine or dec... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real‐world effectiveness of first‐line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy
0
Authors
Fabian Acker
14 more
Fabian Acker
•
Jörg Chromik
12 more
•
Joerg Bittenbring
Published
July 18, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
European Journal Of Haematology
Topics
Computer Science
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1111/ejh.14278
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
European Journal Of Haematology
Topics
Computer Science
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1111/ejh.14278
License
CC-BY-NC-ND
